Literature DB >> 20061365

Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology.

David S Knopman1.   

Abstract

This commentary considers the implications of the association between albuminuria and cognitive decline described by Jassal et al. in this issue of the Journal (Am J Epidemiol. 2010;171(3):290-291). The authors report that men with albuminuria had a greater likelihood than men without albuminuria of experiencing declines in cognitive function over a 6.6-year period. Albuminuria is the result of endothelial damage in the kidney, which, in turn, is the result of microvascular disease. If one of the key mechanisms of brain microvascular disease is leakage of serum proteins into the brain extracellular space, in a fashion parallel to albuminuria that occurs in nephrosclerosis, several facets of cerebrovascular disease and cognitive decline are explained. First, brain microvascular disease would not be recognized by traditional clinical features of cerebrovascular disease because brain microvascular disease occurs gradually and insidiously. Second, the extravasation of serum proteins as a result of brain microvascular disease would account for the perivascular distribution of white matter hyperintensities on magnetic resonance imaging. Albuminuria might be a useful screening test for generalized microvascular disease and, if detected, might reasonably prompt brain imaging and more intensive therapeutic efforts to forestall further endothelial dysfunction in the kidney, brain, and elsewhere.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061365      PMCID: PMC2842197          DOI: 10.1093/aje/kwp429

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

1.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study.

Authors:  H Petrovitch; L R White; G Izmirilian; G W Ross; R J Havlik; W Markesbery; J Nelson; D G Davis; J Hardman; D J Foley; L J Launer
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences.

Authors:  T Pohjasvaara; R Mäntylä; R Ylikoski; M Kaste; T Erkinjuntti
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

4.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  A Lobo; L J Launer; L Fratiglioni; K Andersen; A Di Carlo; M M Breteler; J R Copeland; J F Dartigues; C Jagger; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

5.  Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension.

Authors:  L A Lipsitz; S Mukai; J Hamner; M Gagnon; V Babikian
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

Review 6.  Neuropathologic substrates of ischemic vascular dementia.

Authors:  H V Vinters; W G Ellis; C Zarow; B W Zaias; W J Jagust; W J Mack; H C Chui
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

7.  Kidney function is associated with the rate of cognitive decline in the elderly.

Authors:  Aron S Buchman; D Tanne; P A Boyle; R C Shah; S E Leurgans; D A Bennett
Journal:  Neurology       Date:  2009-08-05       Impact factor: 9.910

8.  A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study.

Authors:  Simerjot K Jassal; Donna Kritz-Silverstein; Elizabeth Barrett-Connor
Journal:  Am J Epidemiol       Date:  2010-01-08       Impact factor: 4.897

9.  Risk factors for dementia in the cardiovascular health cognition study.

Authors:  Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

10.  White matter microstructural integrity and cognitive function in a general elderly population.

Authors:  Meike W Vernooij; M Arfan Ikram; Henri A Vrooman; Piotr A Wielopolski; Gabriel P Krestin; Albert Hofman; Wiro J Niessen; Aad Van der Lugt; Monique M B Breteler
Journal:  Arch Gen Psychiatry       Date:  2009-05
View more
  17 in total

1.  Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.

Authors:  Manjula Kurella Tamura; Nicholas M Pajewski; R Nick Bryan; Daniel E Weiner; Matthew Diamond; Peter Van Buren; Addison Taylor; Srinivasan Beddhu; Clive Rosendorff; Hesamoddin Jahanian; Greg Zaharchuk
Journal:  Neurology       Date:  2016-02-26       Impact factor: 9.910

2.  Association of cognitive function with albuminuria and eGFR in the general population.

Authors:  Hanneke Joosten; Gerbrand J Izaks; Joris P J Slaets; Paul E de Jong; Sipke T Visser; Henk J G Bilo; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

3.  Kidney dysfunction and cognitive decline in women.

Authors:  Imran Sajjad; Francine Grodstein; Jae H Kang; Gary C Curhan; Julie Lin
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-12       Impact factor: 8.237

4.  Polygenic overlap between kidney function and large artery atherosclerotic stroke.

Authors:  Elizabeth G Holliday; Matthew Traylor; Rainer Malik; Stephen Bevan; Jane Maguire; Simon A Koblar; Jonathan Sturm; Graeme J Hankey; Christopher Oldmeadow; Mark McEvoy; Cathie Sudlow; Peter M Rothwell; Josef Coresh; Pavel Hamet; Johanne Tremblay; Stephen T Turner; Mariza de Andrade; Madhumathi Rao; Reinhold Schmidt; Peter A Crick; Antonietta Robino; Carmen A Peralta; J Wouter Jukema; Paul Mitchell; Sylvia E Rosas; Jie Jin Wang; Rodney J Scott; Martin Dichgans; Braxton D Mitchell; W H Linda Kao; Caroline S Fox; Christopher Levi; John Attia; Hugh S Markus
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

5.  Urinary albumin to creatinine ratio as potential biomarker for cerebral microvascular disease.

Authors:  Amanda L Strickland; Heidi C Rossetti; Ronald M Peshock; Myron F Weiner; Paul A Nakonezny; Roderick W McColl; Keith M Hulsey; Sandeep R Das; Kevin S King
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

6.  Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.

Authors:  Christine M Burns; David S Knopman; David E Tupper; Cynthia S Davey; Yelena M Slinin; Kamakshi Lakshminarayan; Rebecca C Rossom; Sarah L Pederson; David T Gilbertson; Anne M Murray
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-02       Impact factor: 6.053

7.  Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study.

Authors:  Joshua I Barzilay; Timothy M Morgan; Anne M Murray; R Nick Bryan; Jeff D Williamson; Adrian Schnall; Lenore J Launer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-19       Impact factor: 6.053

8.  Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness.

Authors:  Sun-Seog Kweon; Min-Ho Shin; Young-Hoon Lee; Jin-Su Choi; Hae-Sung Nam; Kyeong-Soo Park; Do-Hyung Kim; Seul-Ki Jeong
Journal:  Cardiovasc Diabetol       Date:  2012-09-21       Impact factor: 9.951

9.  Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Authors:  Miklós Palkovits; Katarína Šebeková; Kristina Simon Klenovics; Anton Kebis; Gholamreza Fazeli; Udo Bahner; August Heidland
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Decline in kidney function over the course of adulthood and cognitive function in midlife.

Authors:  Sanaz Sedaghat; Farzaneh Sorond; Kristine Yaffe; Stephen Sidney; Holly J Kramer; David R Jacobs; Lenore J Launer; Mercedes R Carnethon
Journal:  Neurology       Date:  2020-09-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.